Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Kallmann syndrome with cardiopathy is characterized by hypogonadotropic hypogonadism associated with gonadotropin-releasing hormone (GnRH) deficiency, anosmia or hyposmia (with hypoplasia or aplasia of the olfactory bulbs) and complex congenital cardiac malformations (double-outlet right ventricle, dilated cardiomyopathy, right aortic arch). It represents a distinct clinical entity from Kallmann syndrome.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Kallmann syndrome-heart disease syndrome.
1 publication has been identified in PubMed for Kallmann syndrome-heart disease syndrome. Research spans Case Report / Case Series (100%).
Hamaichat M (2025). [PMID: 41712788](https://pubmed.ncbi.nlm.nih.gov/41712788/). *Tunis Med*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 12:43 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Kallmann syndrome-heart disease syndrome
AI-curated news mentioning Kallmann syndrome-heart disease syndrome
Updated May 18, 2026
A recent bibliometric analysis highlights emerging trends and research hotspots in Kallmann syndrome, providing insights into future research directions. This study aims to guide researchers and stakeholders in understanding the evolving landscape of this rare condition.